• Return to Headlines

Epizyme Inc Up 85.2% Since SmarTrend Uptrend Call (EPZM)

By Amy Schwartz

SmarTrend identified an Uptrend for Epizyme Inc (NASDAQ:EPZM) on January 4th, 2019 at $6.98. In approximately 2 months, Epizyme Inc has returned 85.24% as of today's recent price of $12.93.

Over the past year, Epizyme Inc has traded in a range of $5.14 to $21.40 and is now at $12.93, 152% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 0.7% while the 50-day MA has advanced 3.9%.

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Epizyme Inc shares.

Log in and add Epizyme Inc (EPZM) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights epizyme inc

Ticker(s): EPZM